GLP1R and type 2 diabetes mellitus: Injectable once-weekly semaglutide for diabetes (OW sema T2D) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that has demonstrated considerable efficacy in improving glycemic control and promoting weight loss in patients with T2DM.